Intended for healthcare professionals

CCBYNC Open access
Research

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study

BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k2693 (Published 18 July 2018) Cite this as: BMJ 2018;362:k2693